FinEdge Labs
D

DHR

DHRUnverified
5 segments tracked|8 years of data|Annual (10-K)
Total Revenue
$24.6B2.9%
FY2025
Operating Segments
5
Active segments
Blended Margin
20.5%
Operating margin
Highest Margin
26.7%
Diagnostics Segment
Segment Shift

Diagnostics Segment has grown from 0.0% to 40.5% of total revenue since FY2018, with 26.7% operating margins. Meanwhile, Biotechnology Segment is the fastest growing at +7.9% YoY.

Segment Revenue Over Time

Revenue Mix

Segment Breakdown — FY2025

SegmentRevenueOp. IncomeMargin% of TotalYoY
Diagnostics Segment$9.9B$2.6B26.7%40.5%+1.6%
Life Sciences Segment$7.3B$520M7.1%29.9%+0.1%
Biotechnology Segment$7.3B$1.9B25.6%29.7%+7.9%

Want more? Unlock the full analysis.

Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.

Get Started Free